Danish studies find higher risk of optic nerve damage with Ozempic

Cercetare și inovare

PAUL IAN CROSS , BSc (Hons), MSc, PhD, is a scientist, writer, author, educator and creative entrepreneur. With over twenty years’ experience in clinical research, Paul has been involved in the design, set-up or delivery of over a hundred clinical studies, including first-in-human clinical trials in gene and cell therapy and COVID-19 vaccine research. Paul provides consultancy services to organisations who oversee or manage clinical research, including clinical trial set-up, ICH Good Clinical

Tag-uri: Coronavirus

Danish studies find higher risk of optic nerve damage with Ozempic https://www.medicalnewstoday.com - 02.01.2025 17:17

din zilele anterioare

Danish studies find higher risk of optic nerve damage with Ozempic https://www.medicalnewstoday.com - 02.01.2025 17:17